{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:11:40Z","timestamp":1793333500869,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Elevations in plasma branched-chain amino acid (BCAA) levels associate with insulin resistance and type 2 diabetes (T2D). Pre-clinical models suggest that lowering BCAA levels improve glucose tolerance, but data in humans are lacking. Here, we used sodium phenylbutyrate (NaPB), an accelerator of BCAA catabolism, as tool to lower plasma BCAA levels in patients with T2D, and evaluate its effect on metabolic health. This trial (NetherlandsTrialRegister: NTR7426) had a randomized, placebo-controlled, double-blind cross-over design and was performed in the Maastricht University Medical Center (MUMC+), the Netherlands, between February 2019 and February 2020. Patients were eligible for the trial if they were 40\u201375years, BMI of 25\u201338\u2009kg\/m\u00b2, relatively well-controlled T2D (HbA1C\u2009&lt;\u20098.5%) and treated with oral glucose-lowering medication. Eighteen participants were randomly assigned to receive either NaPB 4.8\u2009g\/m\u00b2\/day and placebo for 2 weeks via controlled randomization and sixteen participants completed the study. The primary outcome was peripheral insulin sensitivity. Secondary outcomes were ex vivo muscle mitochondrial oxidative capacity, substrate oxidation and ectopic fat accumulation. Fasting blood samples were collected to determine levels of BCAA, their catabolic intermediates, insulin, triglycerides, free fatty acids (FFA) and glucose. NaPB led to a robust 27% improvement in peripheral insulin sensitivity compared to placebo (\u0394Rd:13.2\u2009\u00b1\u20091.8 vs. 9.6\u2009\u00b1\u20091.8 \u00b5mol\/kg\/min,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.02). This was paralleled by an improvement in pyruvate-driven muscle mitochondrial oxidative capacity and whole-body insulin-stimulated carbohydrate oxidation, and a reduction in plasma BCAA and glucose levels. No effects were observed on levels of insulin, triglycerides and FFA, neither did\u00a0fat accumulation\u00a0in muscle and liver change. No adverse events were reported. These data establish the proof-of-concept in humans that modulating the BCAA oxidative pathway may represent a potential treatment strategy for patients with T2D.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-31249-9","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T02:02:33Z","timestamp":1655517753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["A randomized placebo-controlled clinical trial for pharmacological activation of BCAA catabolism in patients with type 2 diabetes"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0005-8523","authenticated-orcid":false,"given":"Froukje","family":"Vanweert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Neinast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmundo Erazo","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tineke","family":"van de Weijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0265-0870","authenticated-orcid":false,"given":"Joris","family":"Hoeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7795-584X","authenticated-orcid":false,"given":"Vera B.","family":"Schrauwen-Hinderling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan C.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5195-6737","authenticated-orcid":false,"given":"Marc R.","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3084-0687","authenticated-orcid":false,"given":"Matthijs K. C.","family":"Hesselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0973-847X","authenticated-orcid":false,"given":"Patrick","family":"Schrauwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1368-2453","authenticated-orcid":false,"given":"Zoltan","family":"Arany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2672-0415","authenticated-orcid":false,"given":"Esther","family":"Phielix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,18]]},"reference":[{"key":"31249_CR1","unstructured":"Organization W. H. Global Report on Diabetes (France; 2016)."},{"key":"31249_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","volume":"46","author":"SE Kahn","year":"2003","unstructured":"Kahn, S. E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46, 3\u201319 (2003).","journal-title":"Diabetologia"},{"key":"31249_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrendo.2011.138","volume":"8","author":"J Szendroedi","year":"2011","unstructured":"Szendroedi, J., Phielix, E. & Roden, M. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 8, 92\u2013103 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"31249_CR4","doi-asserted-by":"publisher","first-page":"e51648","DOI":"10.1371\/journal.pone.0051648","volume":"8","author":"T van de Weijer","year":"2013","unstructured":"van de Weijer, T. et al. Relationships between mitochondrial function and metabolic flexibility in type 2 diabetes mellitus. PLoS ONE 8, e51648 (2013).","journal-title":"PLoS ONE"},{"key":"31249_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard, C. B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9, 311\u2013326 (2009).","journal-title":"Cell Metab."},{"key":"31249_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.2337\/dc12-0895","volume":"36","author":"P Wurtz","year":"2013","unstructured":"Wurtz, P. et al. Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care 36, 648\u2013655 (2013).","journal-title":"Diabetes Care"},{"key":"31249_CR7","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/s41366-021-00815-4","volume":"45","author":"F Vanweert","year":"2021","unstructured":"Vanweert, F. et al. The effect of physical activity level and exercise training on the association between plasma branched-chain amino acids and intrahepatic lipid content in participants with obesity. Int J Obes. 45, 1510\u20131520 (2021).","journal-title":"Int J Obes"},{"key":"31249_CR8","doi-asserted-by":"publisher","first-page":"e1827","DOI":"10.1210\/clinem\/dgaa751","volume":"106","author":"F Vanweert","year":"2021","unstructured":"Vanweert, F. et al. Elevated plasma branched-chain amino acid levels correlate with type 2 diabetes-related metabolic disturbances. J. Clin. Endocrinol. Metab. 106, e1827\u2013e1836 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"31249_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang, T. J. et al. Metabolite profiles and the risk of developing diabetes. Nat. Med 17, 448\u2013453 (2011).","journal-title":"Nat. Med"},{"key":"31249_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2337\/db12-0495","volume":"62","author":"A Floegel","year":"2013","unstructured":"Floegel, A. et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62, 639\u2013648 (2013).","journal-title":"Diabetes"},{"key":"31249_CR11","doi-asserted-by":"publisher","first-page":"E1552","DOI":"10.1152\/ajpendo.00134.2007","volume":"293","author":"P She","year":"2007","unstructured":"She, P. et al. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am. J. Physiol. Endocrinol. Metab. 293, E1552\u2013E1563 (2007).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"31249_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bbrc.2010.02.004","volume":"393","author":"M Doisaki","year":"2010","unstructured":"Doisaki, M. et al. Regulation of hepatic branched-chain alpha-keto acid dehydrogenase kinase in a rat model for type 2 diabetes mellitus at different stages of the disease. Biochem. Biophys. Res Commun. 393, 303\u2013307 (2010).","journal-title":"Biochem. Biophys. Res Commun."},{"key":"31249_CR13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3945\/an.111.000737","volume":"2","author":"SH Adams","year":"2011","unstructured":"Adams, S. H. Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv. Nutr. 2, 445\u2013456 (2011).","journal-title":"Adv. Nutr."},{"key":"31249_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrendo.2014.171","volume":"10","author":"CJ Lynch","year":"2014","unstructured":"Lynch, C. J. & Adams, S. H. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat. Rev. Endocrinol. 10, 723\u2013736 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"31249_CR15","doi-asserted-by":"publisher","first-page":"841S","DOI":"10.1093\/jn\/131.3.841S","volume":"131","author":"RA Harris","year":"2001","unstructured":"Harris, R. A., Kobayashi, R., Murakami, T. & Shimomura, Y. Regulation of branched-chain alpha-keto acid dehydrogenase kinase expression in rat liver. J. Nutr. 131, 841S\u2013845SS (2001).","journal-title":"J. Nutr."},{"key":"31249_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/00075197-200109000-00013","volume":"4","author":"Y Shimomura","year":"2001","unstructured":"Shimomura, Y., Obayashi, M., Murakami, T. & Harris, R. A. Regulation of branched-chain amino acid catabolism: nutritional and hormonal regulation of activity and expression of the branched-chain alpha-keto acid dehydrogenase kinase. Curr. Opin. Clin. Nutr. Metab. Care 4, 419\u2013423 (2001).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"31249_CR17","doi-asserted-by":"publisher","first-page":"20583","DOI":"10.1074\/jbc.M114.569251","volume":"289","author":"SC Tso","year":"2014","unstructured":"Tso, S. C. et al. Benzothiophene carboxylate derivatives as novel allosteric inhibitors of branched-chain alpha-ketoacid dehydrogenase kinase. J. Biol. Chem. 289, 20583\u201320593 (2014).","journal-title":"J. Biol. Chem."},{"key":"31249_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12933-019-0892-3","volume":"18","author":"GM Uddin","year":"2019","unstructured":"Uddin, G. M. et al. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure. Cardiovasc Diabetol. 18, 86 (2019).","journal-title":"Cardiovasc Diabetol."},{"key":"31249_CR19","doi-asserted-by":"publisher","first-page":"172796","DOI":"10.1016\/j.ejphar.2019.172796","volume":"866","author":"K Lian","year":"2020","unstructured":"Lian, K. et al. PP2Cm overexpression alleviates MI\/R injury mediated by a BCAA catabolism defect and oxidative stress in diabetic mice. Eur. J. Pharm. 866, 172796 (2020).","journal-title":"Eur. J. Pharm."},{"key":"31249_CR20","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cmet.2018.04.015","volume":"27","author":"PJ White","year":"2018","unstructured":"White, P. J. et al. The BCKDH kinase and phosphatase integrate BCAA and lipid metabolism via regulation of ATP-citrate lyase. Cell Metab. 27, 1281\u201393 e7 (2018).","journal-title":"Cell Metab."},{"key":"31249_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nm.4057","volume":"22","author":"C Jang","year":"2016","unstructured":"Jang, C. et al. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat. Med 22, 421\u2013426 (2016).","journal-title":"Nat. Med"},{"key":"31249_CR22","doi-asserted-by":"publisher","first-page":"e011625","DOI":"10.1161\/JAHA.118.011625","volume":"8","author":"M Chen","year":"2019","unstructured":"Chen, M. et al. Therapeutic effect of targeting branched-chain amino acid catabolic flux in pressure-overload induced heart failure. J. Am. Heart Assoc. 8, e011625 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"31249_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cmet.2018.10.013","volume":"29","author":"MD Neinast","year":"2019","unstructured":"Neinast, M. D. et al. Quantitative analysis of the whole-body metabolic fate of branched-chain amino acids. Cell Metab. 29, 417\u2013429 e4 (2019).","journal-title":"Cell Metab."},{"key":"31249_CR24","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.2337\/db18-0927","volume":"68","author":"M Zhou","year":"2019","unstructured":"Zhou, M. et al. Targeting BCAA catabolism to treat obesity-associated insulin resistance. Diabetes 68, 1730\u201346. (2019).","journal-title":"Diabetes"},{"key":"31249_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ymgme.2014.06.005","volume":"113","author":"LC Burrage","year":"2014","unstructured":"Burrage, L. C., Jain, M., Gandolfo, L. & Lee, B. H. Members of the Urea Cycle Disorders C, Nagamani SC. Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders. Mol. Genet Metab. 113, 131\u2013135 (2014).","journal-title":"Mol. Genet Metab."},{"key":"31249_CR26","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.2337\/db16-1475","volume":"66","author":"LLS Harris","year":"2017","unstructured":"Harris, L. L. S. et al. Alterations in 3-hydroxyisobutyrate and FGF21 metabolism are associated with protein ingestion-induced insulin resistance. Diabetes 66, 1871\u20131878 (2017).","journal-title":"Diabetes"},{"key":"31249_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ebiom.2017.12.008","volume":"27","author":"A Mardinoglu","year":"2018","unstructured":"Mardinoglu, A. et al. Elevated plasma levels of 3-hydroxyisobutyric acid are associated with incident type 2 diabetes. EBioMedicine 27, 151\u2013155 (2018).","journal-title":"EBioMedicine"},{"key":"31249_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/nu8070405","volume":"8","author":"MS Yoon","year":"2016","unstructured":"Yoon, M. S. The emerging role of branched-chain amino acids in insulin resistance and metabolism. Nutrients. 8, 405 (2016).","journal-title":"Nutrients"},{"key":"31249_CR29","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/s41366-021-00815-4","volume":"45","author":"F Vanweert","year":"2021","unstructured":"Vanweert, F. et al. The effect of physical activity level and exercise training on the association between plasma branched-chain amino acids and intrahepatic lipid content in participants with obesity. Int J. Obes. 45, 1510\u201320. (2021).","journal-title":"Int J. Obes."},{"key":"31249_CR30","doi-asserted-by":"publisher","first-page":"e1827","DOI":"10.1210\/clinem\/dgaa751","volume":"106","author":"F Vanweert","year":"2020","unstructured":"Vanweert, F. et al. Elevated plasma branched-chain amino acid levels correlate with type 2 diabetes-related metabolic disturbances. J. Clin. Endocrinol. Metab. 106, e1827\u2013e1836 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"31249_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00726-011-1088-7","volume":"43","author":"MM Adeva","year":"2012","unstructured":"Adeva, M. M., Calvino, J., Souto, G. & Donapetry, C. Insulin resistance and the metabolism of branched-chain amino acids in humans. Amino Acids 43, 171\u2013181 (2012).","journal-title":"Amino Acids"},{"key":"31249_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/ajcn\/68.1.72","volume":"68","author":"A Suryawan","year":"1998","unstructured":"Suryawan, A. et al. A molecular model of human branched-chain amino acid metabolism. Am. J. Clin. Nutr. 68, 72\u201381 (1998).","journal-title":"Am. J. Clin. Nutr."},{"key":"31249_CR33","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1042\/bj2400909","volume":"240","author":"J Letto","year":"1986","unstructured":"Letto, J., Brosnan, M. E. & Brosnan, J. T. Valine metabolism. Gluconeogenesis from 3-hydroxyisobutyrate. Biochem J. 240, 909\u2013912 (1986).","journal-title":"Biochem J."},{"key":"31249_CR34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11892-018-1048-7","volume":"18","author":"Z Arany","year":"2018","unstructured":"Arany, Z. & Neinast, M. Branched chain amino acids in metabolic disease. Curr. Diab Rep. 18, 76 (2018).","journal-title":"Curr. Diab Rep."},{"key":"31249_CR35","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.2337\/db06-1016","volume":"56","author":"M Krebs","year":"2007","unstructured":"Krebs, M. et al. The mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes 56, 1600\u20131607 (2007).","journal-title":"Diabetes"},{"key":"31249_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cmet.2006.05.003","volume":"3","author":"SH Um","year":"2006","unstructured":"Um, S. H., D\u2019Alessio, D. & Thomas, G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab. 3, 393\u2013402 (2006).","journal-title":"Cell Metab."},{"key":"31249_CR37","doi-asserted-by":"publisher","first-page":"14056","DOI":"10.1073\/pnas.0706517104","volume":"104","author":"F Tremblay","year":"2007","unstructured":"Tremblay, F. et al. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc. Natl Acad. Sci. USA 104, 14056\u201314061 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"31249_CR38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tem.2006.01.005","volume":"17","author":"AC Thirone","year":"2006","unstructured":"Thirone, A. C., Huang, C. & Klip, A. Tissue-specific roles of IRS proteins in insulin signaling and glucose transport. Trends Endocrinol. Metab. 17, 72\u201378 (2006).","journal-title":"Trends Endocrinol. Metab."},{"key":"31249_CR39","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/S0021-9258(18)33067-9","volume":"258","author":"RH Jackson","year":"1983","unstructured":"Jackson, R. H. & Singer, T. P. Inactivation of the 2-ketoglutarate and pyruvate dehydrogenase complexes of beef heart by branched chain keto acids. J. Biol. Chem. 258, 1857\u20131865 (1983).","journal-title":"J. Biol. Chem."},{"key":"31249_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cmet.2016.11.005","volume":"25","author":"T Li","year":"2017","unstructured":"Li, T. et al. Defective branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia-reperfusion injury. Cell Metab. 25, 374\u2013385 (2017).","journal-title":"Cell Metab."},{"key":"31249_CR41","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1007\/s00125-010-1764-2","volume":"53","author":"E Phielix","year":"2010","unstructured":"Phielix, E., Meex, R., Moonen-Kornips, E., Hesselink, M. & Schrauwen, P. Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals. Diabetologia 53, 1714\u20131721 (2010).","journal-title":"Diabetologia"},{"key":"31249_CR42","doi-asserted-by":"publisher","first-page":"572","DOI":"10.2337\/db09-1322","volume":"59","author":"RC Meex","year":"2010","unstructured":"Meex, R. C. et al. Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity. Diabetes 59, 572\u2013579 (2010).","journal-title":"Diabetes"},{"key":"31249_CR43","doi-asserted-by":"publisher","first-page":"E1175","DOI":"10.1152\/ajpendo.00630.2012","volume":"304","author":"DE Lackey","year":"2013","unstructured":"Lackey, D. E. et al. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am. J. Physiol. Endocrinol. Metab. 304, E1175\u2013E1187 (2013).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"31249_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ymgme.2013.05.010","volume":"109","author":"HA Zimmerman","year":"2013","unstructured":"Zimmerman, H. A., Olson, K. C., Chen, G. & Lynch, C. J. Adipose transplant for inborn errors of branched chain amino acid metabolism in mice. Mol. Genet Metab. 109, 345\u2013353 (2013).","journal-title":"Mol. Genet Metab."},{"key":"31249_CR45","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.metabol.2015.01.008","volume":"64","author":"BA Irving","year":"2015","unstructured":"Irving, B. A. et al. Effect of insulin sensitizer therapy on amino acids and their metabolites. Metabolism 64, 720\u2013728 (2015).","journal-title":"Metabolism"},{"key":"31249_CR46","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1749-6632.1959.tb44923.x","volume":"82","author":"R Steele","year":"1959","unstructured":"Steele, R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann. N. Y Acad. Sci. 82, 420\u2013430 (1959).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"31249_CR47","first-page":"2220","volume":"86","author":"MT Ackermans","year":"2001","unstructured":"Ackermans, M. T. et al. The quantification of gluconeogenesis in healthy men by (2)H2O and [2-(13)C]glycerol yields different results: rates of gluconeogenesis in healthy men measured with (2)H2O are higher than those measured with [2-(13)C]glycerol. J. Clin. Endocrinol. Metab. 86, 2220\u20132226 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"31249_CR48","first-page":"213","volume":"6","author":"JB Weir","year":"1990","unstructured":"Weir, J. B. New methods for calculating metabolic rate with special reference to protein metabolism. 1949. Nutrition 6, 213\u2013221 (1990).","journal-title":"Nutrition"},{"key":"31249_CR49","first-page":"628","volume":"55","author":"KN Frayn","year":"1983","unstructured":"Frayn, K. N. Calculation of substrate oxidation rates in vivo from gaseous exchange. J. Appl Physiol. Respir. Environ. Exerc Physiol. 55, 628\u2013634 (1983).","journal-title":"J. Appl Physiol. Respir. Environ. Exerc Physiol."},{"key":"31249_CR50","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1748-1716.1967.tb03720.x","volume":"71","author":"J Bergstrom","year":"1967","unstructured":"Bergstrom, J., Hermansen, L., Hultman, E. & Saltin, B. Diet, muscle glycogen and physical performance. Acta Physiol. Scand. 71, 140\u2013150 (1967).","journal-title":"Acta Physiol. Scand."},{"key":"31249_CR51","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0005-2728(87)90174-5","volume":"892","author":"VI Veksler","year":"1987","unstructured":"Veksler, V. I., Kuznetsov, A. V., Sharov, V. G., Kapelko, V. I. & Saks, V. A. Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim. Biophys. Acta 892, 191\u2013196 (1987).","journal-title":"Biochim. Biophys. Acta"},{"key":"31249_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15684-0","volume":"11","author":"KHM Roumans","year":"2020","unstructured":"Roumans, K. H. M. et al. Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance. Nat. Commun. 11, 1891 (2020).","journal-title":"Nat. Commun."},{"key":"31249_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3945\/ajcn.114.094730","volume":"101","author":"L Lindeboom","year":"2015","unstructured":"Lindeboom, L. et al. Proton magnetic resonance spectroscopy reveals increased hepatic lipid content after a single high-fat meal with no additional modulation by added protein. Am. J. Clin. Nutr. 101, 65\u201371 (2015).","journal-title":"Am. J. Clin. Nutr."},{"key":"31249_CR54","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10334-003-0029-1","volume":"16","author":"M Krssak","year":"2004","unstructured":"Krssak, M., Mlynarik, V., Meyerspeer, M., Moser, E. & Roden, M. 1H NMR relaxation times of skeletal muscle metabolites at 3 T. MAGMA 16, 155\u2013159 (2004).","journal-title":"MAGMA"},{"key":"31249_CR55","doi-asserted-by":"publisher","first-page":"9818","DOI":"10.1021\/ac1021166","volume":"82","author":"E Melamud","year":"2010","unstructured":"Melamud, E., Vastag, L. & Rabinowitz, J. D. Metabolomic analysis and visualization engine for LC-MS data. Anal. Chem. 82, 9818\u20139826 (2010).","journal-title":"Anal. Chem."},{"key":"31249_CR56","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1021\/acs.analchem.7b00396","volume":"89","author":"X Su","year":"2017","unstructured":"Su, X., Lu, W. & Rabinowitz, J. D. Metabolite spectral accuracy on orbitraps. Anal. Chem. 89, 5940\u20135948 (2017).","journal-title":"Anal. Chem."},{"key":"31249_CR57","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/ijo.2010.250","volume":"35","author":"G Plasqui","year":"2011","unstructured":"Plasqui, G., Soenen, S., Westerterp-Plantenga, M. S. & Westerterp, K. R. Measurement of longitudinal changes in body composition during weight loss and maintenance in overweight and obese subjects using air-displacement plethysmography in comparison with the deuterium dilution technique. Int J. Obes. 35, 1124\u20131130 (2011).","journal-title":"Int J. Obes."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31249-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31249-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31249-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T12:56:08Z","timestamp":1669294568000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31249-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,18]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["31249"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-31249-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,18]]},"assertion":[{"value":"16 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3508"}}